| |
Editors-in-Chief E. Sylvester Vizi, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, P.O. Box 67, Hungary. Tel.: +36 1 210 9421; Fax: +36 1 210 9424, E-mail:
[email protected] Roger F. Butterworth, Neuroscience Research Unit, (Hoˆpital) Pavillon Saint-Luc-CHUM (Universite´ de Montre´al), 1058 St Denis Street, Montre´al, Que´bec, Canada H2X 3J4, Tel.: +1514 890 8310 ext 35759; Fax: +1514 412 7314, E-mail:
[email protected]
Associate Editors Adrian Dunn, Louisiana State University Health Science Center, Shreveport, LA, USA Josef Krieglstein, Institute of Pharmacology and Toxicology, Marburg, Germany George Kunos, National Institute for Alcohol Abuse and Alcoholism, Bethesda, MD, USA David L. Martin, Wadsworth Center, New York State Health Department, NY, USA Max Re´casens, Universite´ Montpellier II, Montpellier, France Arne Schousboe, PharmaBiotec Research Center, Copenhagen, Denmark Yukio Yoneda, Kanazawa University, Ishikawa, Japan
Editor Emeritus Neville N. Osborne, University of Oxford, Oxford, UK
Editorial Advisory Board T. Balla, National Institutes of Health, Bethesda, MD, USA A. S. Basile, National Institutes of Health, Bethesda, MD, USA A. Bax, NIH, Bethesda, MD, USA S. C. Bondy, University of California, Irvine, CA, USA G. Dienel, University Arkansas for Medical Sciences, Little Rock, AR, USA P. Dodd, University of Queensland, Queensland, Australia K. G. Fuxe, Karolinska Institute, Stockholm, Sweden G. Gibson, Burke Medical Research Institute, White Plains, NY, USA D. D. Gilboe, University of Wisconsin Medical School, Madison, WI, USA M. Go¨thert, Institute of Pharmacology and Toxicology, University of Bonn, Bonn, Germany M. Hamon, INSERM U288, Paris, France L. G. Ha´rsing, EGIS Pharmaceuticals Ltd., Budapest, Hungary P. Illes, University of Leipzig, Leipzig, Germany F. Ito, Setsunan University, Osaka, Japan M. P. Mattson, National Institute on Aging, Baltimore, MD, USA
M. Raiteri, Istituto di Farmacologia, Genoa, Italy T. A. Reader, University of Montre´al, Montre´al, Canada P. J. Richardson, University of Cambridge, Cambridge, UK M. B. Robinson, Abramson Research Center, Philadelphia, PA, USA N. Saito, Kobe University, Kobe, Japan L. S. Satin, Medical College of Virginia, Richmond, VA, USA N. Sims, Flinders University, Adelaide, Australia M. Smith, Case Western Reserve University, Cleveland, Ohio, USA U. Sonnewald, N. T. N. U., Trondheim, Norway H. Ueda, Nagasaki University School of Pharmacological Sciences, Nagasaki, Japan M. Vignes, Universite´ de Montpellier II, Montpellier, France E. Weihe, University of Marburg, Marburg, Germany R. Wenthold, National Institutes of Health, Bethesda, MD, USA J. J. Woodward, Virginia Commonwealth University, Richmond, VA, USA H. Zimmermann, Jw Goethe University Biozentrum, Frankfurt am Main, Germany
# 2003 Elsevier Science Ltd. All rights reserved. Published monthly with additional issues in January and July - two volumes per annum Author enquiries: For enquiries relating to the submission of articles (including electronic submission where available) please visit the Author Gateway from Elsevier Science at http://authors.elsevier.com. The Author Gateway also provides the facility to track accepted articles and set up e-mail alerts to inform you of when an article’s status has changed, as well as detailed artwork guidelines, copyright information, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided after registration of an article for publication. Publication information: Neurochemistry International (ISSN 0197-0186). For 2003, volumes 42–43 are scheduled for publication. Subscription prices are available upon request from the Publisher or from the Regional Sales Office nearest you or from this journal’s website (http://www.elsevier.com/locate/neuint). Further information is available on this journal and other Elsevier Science products through Elsevier’s website: (http://www.elsevier.com). Subscriptions are accepted on a prepaid basis only and are entered on a calendar year basis. Issues are sent by standard mail (surface within Europe, air delivery outside Europe). Priority rates are available upon request. Claims for missing issues should be made within six months of the date of dispatch. USA mailing notice: Neurochemistry International (ISSN 0197-0186) is published monthly in 2 volumes with additional issues in January and July by Elsevier Science Ltd., (P.O. Box 211, 1000 AE Amsterdam, The Netherlands). Annual subscription price in the USA US$ 1506.00 (valid in North, Central and South America), including air speed delivery. Periodical postage rate paid at Jamaica, NY 11431. USA POSTMASTER: Send address changes to Neurochemistry International, Publications Expediting Inc., 200 Meacham Ave, Elmont, NY 11003. AIRFREIGHT AND MAILING in the USA by Publications Expediting Inc., 200 Meacham Avenue, Elmont, NY 11003.
PII: S 0 1 9 7 - 0 1 8 6 ( 0 2 ) 0 0 1 7 6 - 6
| |